Inhibition of growth of MCF-7 MIII human breast carcinoma in nude mice by treatment with agonists or antagonists of LH-RH

This publication has 41 references indexed in Scilit:

• Histological changes in dunning prostate tumors and testes of rats treated with LH‐RH antagonist SB‐75
  The Prostate, 1991
• Grwoth Inhibition of Mouse MXT Mammary Tumor by the Luteinizing Hormone-Releasing Hormone Antagonist SB-75
  JNCI Journal of the National Cancer Institute, 1990
• Compared effects of GnRH analogs and 4-hydroxytamoxifen on growth and steroid receptors in antiestrogen sensitive and resistant MCF-7 breast cancer cell sublines
  Breast Cancer Research and Treatment, 1990
• Characteristics and distribution of receptors for [d‐trp⁶]‐ luteinizing hormone‐releasing hormone, somatostatin, epidermal growth factor, and sex steroids in 500 biopsy samples of human breast cancer
  Journal of Clinical Laboratory Analysis, 1989
• Zoladex in the Treatment of Premenopausal Metastatic Breast Cancer Patients
  Hormone Research, 1989
• Inhibition of the pituitary-gonadal axis by a single intramuscular administration of D-trp-6-LH-RH (decapeptyl) in a sustained-release formulation in patients with prostatic carcinoma
  The Prostate, 1989
• Combined effects of Buserelin, estradiol and Tamoxifen on the growth of MCF-7 human breast cancer cells in vitro
  Biochemical and Biophysical Research Communications, 1986
• Growth of human breast cancer cells inhibited by a luteinizing hormone-releasing hormone agonist
  Nature, 1985
• TREATMENT WITH A LUTEINISING-HORMONE-RELEASING-HORMONE ANALOGUE (BUSERELIN) IN PREMENOPAUSAL PATIENTS WITH METASTATIC BREAST CANCER
  The Lancet, 1982
• ON THE TREATMENT OF INOPERABLE CASES OF CARCINOMA OF THE MAMMA: SUGGESTIONS FOR A NEW METHOD OF TREATMENT, WITH ILLUSTRATIVE CASES.1
  The Lancet, 1896